成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Frontiers in Immunology >>article
Frontiers in Immunology

Frontiers in Immunology

IF: 5.7
Download PDF

Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective.

Published:1 January 2022 DOI: 10.3389/fimmu.2022.1072007 PMID: 36618414
Wei Yu, Iqra Ilyas, Xuerui Hu, Suowen Xu, Hui Yu

Abstract

Epidemiological studies have shown that the incidence, prevalence and mortality of atherosclerotic cardiovascular disease (ASCVD) are increasing globally. Atherosclerosis is characterized as a chronic inflammatory disease which involves inflammation and immune dysfunction. P. lactiflora Pall. is a plant origin traditional medicine that has been widely used for the treatment of various diseases for more than a millennium in China, Japan and Korean. Paeoniflorin is a bioactive monomer extracted from P. lactiflora Pall. with anti-atherosclerosis effects. In this article, we comprehensively reviewed the potential therapeutic effects and molecular mechanism whereby paeoniflorin protects against atherosclerosis from the unique angle of inflammation and immune-related pathway dysfunction in vascular endothelial cells, smooth muscle cells, monocytes, macrophages, platelets and mast cells. Paeoniflorin, with multiple protective effects in atherosclerosis, has the potential to be used as a promising therapeutic agent for the treatment of atherosclerosis and its complications. We conclude with a detailed discussion of the challenges and future perspective of paeoniflorin in translational cardiovascular medicine.

Similar articles

IF:5.3

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer.

ACS Applied Nano Materials Jennifer Ferris, Margarita Espona-Fiedler,etc Published: 21 July 2020
IF:2.6

Ezetimibe therapy: mechanism of action and clinical update.

Vascular Health and Risk Management Binh An P Phan,?Thomas D Dayspring,etc Published: 1 January 2012
IF:4.4

Mechanism of action of 5-arninosalicylic acid.

Mediators of Inflammation N A Punchard, S M Greenfield,etc Published: 1 January 1992